Benzothiazinones: prodrugs that covalently modify the decaprenylphosphoryl-[beta]-D-ribose 2'-epimerase DprE1 of Mycobacterium tuberculosis

MLA

Trefzer, Claudia, et al. “Benzothiazinones: Prodrugs That Covalently Modify the Decaprenylphosphoryl-[Beta]-D-Ribose 2’-Epimerase DprE1 of Mycobacterium Tuberculosis.” Journal of the American Chemical Society, vol. 132, no. 39, Oct. 2010, p. 13663. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.238539674&authtype=sso&custid=ns315887.

APA

Trefzer, C., Rengifo-Gonzalez, M., Hinner, M. J., Schneider, P., Makarov, V., Cole, S. T., & Johnsson, K. (2010). Benzothiazinones: prodrugs that covalently modify the decaprenylphosphoryl-[beta]-D-ribose 2’-epimerase DprE1 of Mycobacterium tuberculosis. Journal of the American Chemical Society, 132(39), 13663.

Chicago

Trefzer, Claudia, Monica Rengifo-Gonzalez, Marlon J. Hinner, Patricia Schneider, Vadim Makarov, Stewart T. Cole, and Kai Johnsson. 2010. “Benzothiazinones: Prodrugs That Covalently Modify the Decaprenylphosphoryl-[Beta]-D-Ribose 2’-Epimerase DprE1 of Mycobacterium Tuberculosis.” Journal of the American Chemical Society 132 (39): 13663. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.238539674&authtype=sso&custid=ns315887.